Madrigal Pharmaceuticals, Inc., a US-based biopharmaceutical company focused on delivering novel therapeutics for metabo...
China-based Innovent Biologics, Inc. has announced a strategic collaboration with Eli Lilly and Company, in the US, to a...
The National Medical Products Administration (NMPA) has approved the OncoMate® Microsatellite Instability (MSI) Dete...
In response to the growing demand amid Hong Kong’s rapidly ageing population for healthcare professionals such as ...
Frontage Laboratories, Inc., a global Contract Research, Development and Manufacturing Organization (CRDMO), has announc...
AstraZeneca strengthens its weight management portfolio through a new strategic collaboration agreement with China-based...
AstraZeneca has announced $15 billion investment in China through 2030 to expand medicines manufacturing and R&D. Th...
WuXi Biologics, a global leading Contract Research, Development and Manufacturing Organization (CRDMO), and HanchorBio I...
China-based Simcere Pharmaceutical Group and Germany-headquartered Boehringer Ingelheim have announced a license and col...
Sisram Medical, a global wellness group offering Energy-Based Devices (EBD), injectables, and other complementary soluti...
US-based AbelZeta Pharma, Inc., a global clinical-stage biopharmaceutical company focused on the discovery and developme...
Zylox-Tonbridge, a Hong Kong-listed medical technology company focused on neuro-and peripheral vascular interventional p...
China-based startup Zonsen PepLib Biotech Inc. has entered into a worldwide license agreement with Novartis for an undis...
China-based startup ElpasBio Holdings, a leading clinical-stage biotechnology company focused on regenerative medicine, ...
China-based WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has...
China-based MediLink Therapeutics has entered into a new collaboration and exclusive licensing agreement with Roche for ...
Ribo Life Science Co., a leading company in small interfering RNA (siRNA) therapeutics, has successfully listed on the M...
Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...
Insilico Medicine, a clinical-stage drug discovery and development company driven by generative artificial intelligence ...
Indian pharma major Lupin Limited has entered into an exclusive License, Supply and Distribution agreement with Gan &...
In alignment with the national framework for the advancement of proton therapy, facilitated by the National Cancer Cente...
The Hong Kong Polytechnic University (PolyU) has developed an acid-resistant “ultra-stable mucus-inspired hydrogel...
China-based Jacobio Pharma has entered an agreement with AstraZeneca for its proprietary Pan-KRAS inhibitor JAB-23E73.&n...
China and US based Harbour BioMed has announced a multi-year, global strategic collaboration and license agreement ...
Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of India-based Glenmark Pharmaceuticals, has entered into an e...
Germany-based Merz Aesthetics, the world’s largest dedicated medical aesthetics business, has launched flagship pr...
Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery company headquartered ...
D3 Bio, a global clinical-stage biotechnology company focused on the discovery and development of innovative oncology th...
China's Fosun Pharma announced that its subsidiaries, Chongqing Yao Pharmaceutical Company, Shanghai Fosun Pharmaceutica...
Pillar Biosciences and AstraZeneca have announced an expansion of their existing laboratory access programme for NG...
Biosparc’s landmark project in Suzhou Industrial Park reached structural completion. On 20 November 2025 the firm ...
China has reached a major milestone in global pharmaceutical innovation. According to the latest report from Clarivate, ...
Australia's Imugene has entered a strategic co-development collaboration with Chinese startup JW Therapeutics to evaluat...
The 93rd API China, held from November 12 to 14, 2025, at the Chongqing International Expo ...
The 93rd API China, China’s first and longest-running pharmaceutical ingredients exhibition, took place from 12&nd...
CytoMed Therapeutics, a Singapore-based clinical stage biopharmaceutical startup focused on harnessing its proprietary n...
As a key step in Bayer’s “In China, for Global” strategy, the Bayer E-Town Open Innovation Center offi...
Singleron Biotechnologies has announced that its Matrix NEO™ automated single cell processing system has...
The establishment of Hong Kong's third medical school at The Hong Kong University of Science and Technology (HKUST) has ...
Sciex, a global leader in life science analytical technologies, has announced the localisation of its X500R QTOF system,...
China-based startup Cornerstone Robotics, a leading global innovator in surgical robotics, has announced the closing of ...
API China, the China International Pharmaceutical Ingredients, Intermediates, Packaging and Equipment Trade Fair, offici...
China-based startups Sanyou Bio and Yugong Bio have announced the signing of a strategic cooperation agre...
Hong Kong-based Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-driven drug discovery compan...
In a special conversation with BioSpectrum Asia, Yang Huang, Head of China Healthcare Research at J.P. Morgan, shares sh...
Clariant, a global specialty chemicals leader, has announced the completion of its state-of-the-art facility expansion a...
Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the com...
Harbour BioMed, a global biopharmaceutical company committed to the discovery and development of novel antibod...
Novo Nordisk has announced the launch of Wegovy® in Hong Kong, now available at private clinics and selected pharmac...
A Chinese man who lost all four limbs in a high-voltage electrical accident 13 years ago can now play chess and racing g...
HPV and PCV are the leading vaccines in the self-paid market in China. According to the WHO vaccine market report 2024, ...
China's Qyuns Therapeutics has entered into a global exclusive collaboration and license agreement with F. Hoffmann-La R...
Everest Medicines, a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commer...
KLN Logistics has announced a strategic partnership between its healthcare subsidiary, KLN Medical and global medic...
A clinical oncology research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), in collaboration...
The Hong Kong University of Science and Technology (HKUST) has launched SmartPath, a comprehensive artificial intel...
API China, Asia’s authoritative exhibition for pharmaceutical ingredients and manufacturing, will convene its 93rd...
The Hong Kong Polytechnic University (PolyU) has received funding support of HK$5 million from Vision Science and Techno...
Jacobio Pharma has announced that its subsidiary Beijing Jacobio Pharmaceuticals Co. has entered into a Capital Increase...
A team of researchers from Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine) and China's ...
Roche has announced its strategic collaboration with the Office for Attracting Strategic Enterprises (OASES) to accelera...
Mirxes, a leading and only publicly-listed molecular cancer early detection company in Asia Pacific, has bee...
Image Caption: (From left) :: Ashok Pandit, Group Chief Corporate Officer, IHH Healthcare | Dr Prem Kumar Nair...
Pier 88 Health, a digital health company dedicated to reshaping chronic pain management and bringing breakthrough global...
Health Hope Pharma (HHP), a clinical-stage oncology biopharma company headquartered in Hong Kong, has entered into ...
China's WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has ann...
Simcere Pharmaceuticals Group has launched QUVIVIQ® (daridorexant) in China. In 2022, Idorsia an...
Innovent Biologics, Inc. has announced that China's National Medical Products Administration (NMPA) has approved mazduti...
Mabwell (Shanghai) Bioscience and US-based Aditum Bio have announced the launch of Kalexo Bio, a new company formed in c...
China-based MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovatio...
US-based Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science...
China-based startup Epigenic Therapeutics, a clinical-stage innovative drug development company, has announced the compl...
Biocytogen Pharmaceuticals (Beijing), a global biotechnology company that drives the research and development of no...
China's Argo Biopharmaceutical, a clinical-stage biotechnology company focused on developing next-generation siRNA thera...
Soft tissue deformation during body movement has long posed a challenge to achieving optimal garment fit and comfort, pa...
Rousselot, Darling Ingredients’ health brand, has been granted patents in Europe, Japan and China for Colartix, it...
Since the introduction of Chapter 18A in 2018, Hong Kong has become an important fundraising hub for biotechnology, givi...
ChemPartner, a leading global Contract Research Organization (CRO) and Contract Development and Manufacturing Organizati...
Hong Kong Metropolitan University (HKMU) recently achieved its first-ever technology licensing agreement, a milestone in...
Neusoft Medical Systems has announced that its NeuViz P10 photon-counting CT has received market approval from China's N...
Developing effective antiviral drugs against mosquito-borne viruses like dengue and Zika requires understanding the func...
Sustainable drug manufacturing is becoming increasingly vital in the global pharmaceutical industry, as drugmakers ...
The Hong Kong Polytechnic University (PolyU) has signed an agreement with Panmedi to further collaborate&...
Robocore Technology Limited (Robocore), a partner company of Hong Kong Science and Technology Parks Corporation (HKSTP),...
Eisai Co. has announced that the in-house discovered and developed orexin receptor antagonist DAYVIGO® (brand name i...
A research team from Hong Kong Baptist University (HKBU) has successfully developed a “Sequential Measurement Base...
WuXi Biologics, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has announced t...
China-based Kexing Biopharm has entered into a comprehensive strategic partnership with IQVIA, a global leader...
China-based Fosun Pharma has signed a license agreement with Expedition Therapeutics Inc. to grant the rights to de...
Codex Genetics, one of the leading precision diagnostics companies in Hong Kong, has announced an exclusive collaboratio...
Biocair, an established global leader in life science logistics, has announced further expansion of its operations in th...
XtalPi, a China-based technology company in integrating artificial intelligence (AI) and robotics for drug and materials...
Arrowhead Pharmaceuticals, Inc. has announced the signing of an asset purchase agreement between Sanofi and Visirna Ther...
The Department of Rehabilitation Sciences at The Hong Kong Polytechnic University (PolyU) recently hosted the inaugural ...
The Hong Kong University of Science and Technology (HKUST) and Union Hospital, Tongji Medical College, Huazhong Universi...
Dr. Falk Pharma GmbH, a Germany-headquartered research-based pharmaceutical company specialising in digestive and metabo...
What are your plans for capacity expansion in biologics and ADC manufacturing? We are already among the largest biologi...
Tigermed, a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical...
GSK plc has entered into agreements with China-based Hengrui Pharma to develop up to 12 innovative medicines, adding sig...
A cross-disciplinary research team from The Chinese University of Hong Kong (CUHK)’s Faculty of Medicine and Facul...
